POMDOCTOR LIMITED American Depositary Shares (POM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, POMDOCTOR LIMITED American Depositary Shares (POM) has a cash flow conversion efficiency ratio of 0.033x as of March 2020. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.08 Billion) by net assets ($32.48 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See POMDOCTOR LIMITED American Depositary Sh balance sheet independence to measure how much of total assets are equity-financed.
POMDOCTOR LIMITED American Depositary Shares - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how POMDOCTOR LIMITED American Depositary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check POM operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
POMDOCTOR LIMITED American Depositary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of POMDOCTOR LIMITED American Depositary Shares ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SSP Group PLC
LSE:SSPG
|
1.962x |
|
Austin Gold Corp
NYSE MKT:AUST
|
-0.013x |
|
SciDev Limited
F:INFA
|
0.025x |
|
Peruvian Metals Corp
V:PER
|
-0.001x |
|
Urteste SA
WAR:URT
|
-0.182x |
|
Clarkson
LSE:CKN
|
0.295x |
|
CNFinance Holdings Ltd
NYSE:CNF
|
-0.012x |
|
Ennogie Solar Group A/S
CO:ESG
|
0.192x |
Annual Cash Flow Conversion Efficiency for POMDOCTOR LIMITED American Depositary Shares (2003–2024)
The table below shows the annual cash flow conversion efficiency of POMDOCTOR LIMITED American Depositary Shares from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see POMDOCTOR LIMITED American Depositary Sh market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-2.09 Billion | $-16.13 Million | 0.008x | -67.02% |
| 2023-12-31 | $-1.96 Billion | $-45.80 Million | 0.023x | +101.27% |
| 2022-12-31 | $-1.90 Billion | $-22.02 Million | 0.012x | +31.49% |
| 2021-12-31 | $-1.78 Billion | $-15.68 Million | 0.009x | -92.16% |
| 2020-12-31 | $-309.35 Million | $-34.80 Million | 0.112x | +332.60% |
| 2019-12-31 | $3.27 Billion | $85.00 Million | 0.026x | -90.75% |
| 2018-12-31 | $30.76 Billion | $8.64 Billion | 0.281x | +12.15% |
| 2017-12-31 | $29.86 Billion | $7.48 Billion | 0.251x | -23.35% |
| 2016-12-31 | $25.84 Billion | $8.45 Billion | 0.327x | +53.61% |
| 2015-12-31 | $4.41 Billion | $939.00 Million | 0.213x | +7.69% |
| 2014-12-31 | $4.32 Billion | $854.00 Million | 0.198x | +71.55% |
| 2013-12-31 | $4.32 Billion | $497.00 Million | 0.115x | -13.50% |
| 2012-12-31 | $4.45 Billion | $592.00 Million | 0.133x | -15.84% |
| 2011-12-31 | $4.34 Billion | $686.00 Million | 0.158x | +88.51% |
| 2010-12-31 | $703.00 Million | $59.00 Million | 0.084x | +1966.11% |
| 2009-12-31 | $10.83 Billion | $44.00 Million | 0.004x | -65.59% |
| 2008-12-31 | $11.10 Billion | $131.00 Million | 0.012x | -3.54% |
| 2007-12-31 | $10.38 Billion | $127.00 Million | 0.012x | +77.75% |
| 2006-12-31 | $9.88 Billion | $68.00 Million | 0.007x | +85.86% |
| 2005-12-31 | $9.18 Billion | $34.00 Million | 0.004x | -46.21% |
| 2004-12-31 | $8.28 Billion | $57.00 Million | 0.007x | -66.55% |
| 2003-12-31 | $8.06 Billion | $166.00 Million | 0.021x | -- |
About POMDOCTOR LIMITED American Depositary Shares
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company's busines… Read more